Health: Saving Lives and Livelihoods

Health: Saving Lives and Livelihoods
People, companies, and countries came together to help each other through the COVID-19 crisis. With a Covid-19 vaccine ready to go, there is hope. Beneath the gloomy and dramatic coronavirus headlines are stories of collaboration and dedication.
Industry Luncheon

Health: Saving Lives and Livelihoods



About the Event

People, companies, and countries came together to help each other through the COVID-19 crisis. With a Covid-19 vaccine ready to go, there is hope. Beneath the gloomy and dramatic coronavirus headlines are stories of collaboration and dedication.

Australia has worked with international counterparts, sharing information on vaccine clinical trials, manufacturing, and safety. Whilst the fallout from the pandemic will continue and we need to plan for and combat these challenges; we are open for business.

Adelaide is home to one of the largest health precincts in the Southern Hemisphere consisting of global and homegrown companies known for their excellence and innovation. Together with key R&D technology, data analytics, machine learning and advanced manufacturing expertise; Adelaide offers the infrastructure, safety, and security to do business in health and medical.

Medicine and health sciences are particular strengths of Adelaide's research and tertiary education sector; in addition Adelaide is an attractive location for fast, cost-effective and high-quality clinical trials: And we have a burgeoning commercial industry, based in Adelaide, helping jurisdictions around the world improve the lives of older people, the Global Centre for Modern Ageing (GCMA).

Find out how the Health sector is improving lives and livelihoods and what opportunities are available for business.




Michael Kleine
US Consul General to VIC, SA, Tas and NT

Matthew Tucker
President and CEO, GE Healthcare Australia, New Zealand and PNG


Elizabeth de Somer
CEO, Medicines Australia


Paul Flynn
CEO, The Hospital Research Foundation Group


Partnered with

   
                            

    


                      


AmCham Australia is committed to data privacy and protecting your personal information. By registering for this event, you agree that AmCham and its event partners may send you relevant information.


Event Details

Date Friday 30 April 2021
Time 11:45 AM - 2:00 PM 
Location Adelaide Convention Centre, North Terrace, Adelaide


Pricing

  Member   Non-Member
Individual (1) $169  $209
Table (10) $1,690  $2,090


Speaker Biographies

Michael Kleine, US Consul General to VIC, SA, TAS and NT
 

Michael Kleine is a Senior Foreign Service Officer with nearly twenty years of experience in the U.S. Department of State.
Prior to his August 2018 arrival in Melbourne, Michael served three years as Deputy Chief of Mission at the U.S. Embassy in Vientiane, Laos. He worked previously in South Korea, where he led Embassy efforts to ratify the U.S.-Korea Free Trade Agreement; Kosovo, where he supported the establishment of democratic institutions in post-war Kosovo; and Vietnam, where he was among the first to work in the U.S. Consulate General in Ho Chi Minh City. From 2013 to 2014, he served as the U.S. Trade Representative’s Senior Advisor for Japan and Korea Trade Policy.

Before joining the diplomatic corps, Michael practiced law in Washington, D.C. He earned both his undergraduate and law degrees at Duke University. He also has a master’s degree in national security strategy from the National War College in Washington.

Michael is accompanied in Melbourne by his wife, Hiroko, and two children.


Elizabeth de Somer, CEO, Medicines Australia

Elizabeth de Somer has over 20 years’ experience in health care and pharmaceutical health policy including drug development, clinical research, manufacturing, drug safety, regulatory affairs, and medicines and vaccines health policy. Elizabeth also contributes her clinical and industry expertise to a number of expert committees providing advice to Government, including representing the industry on the sub-committees to the Pharmaceutical Benefits Advisory Committee (PBAC) [the Economic Sub-Committee ESC and Drug Utilisation Sub-Committees DUSC]. Elizabeth's academic qualifications lie in medical sciences and drug development, which lead her to provide occasional lectures on drug development, regulation of medicines, quality use of medicines and the policy environment affecting access to medicines in Australia. Elizabeth is the Chief Executive Officer at Medicines Australia, the peak body representing research based pharmaceutical companies in Australia, where she leads collaboration with government and the development of sound policies to support access to prescription medicines for Australian patients.


Matthew Tucker, President and CEO, GE Healthcare Australia, New Zealand and PNG
 

Matt Tucker is the President and CEO for GE Healthcare in Australia, New Zealand and PNG. Matt joined GE Healthcare as General Manager for Ultrasound, a position he held from September 2012 through to April 2016. Matt has been an Executive Director of GE Healthcare Australia Pty Ltd since June 2015. Matt also sits on the executive leadership team of General Electric for A&NZ and PNG. Matt has been an executive in Healthcare capital equipment within A&NZ and Asia, delivering strong growth, leveraging his earlier commercial and clinical career, in Diagnostic Imaging and Ultrasound. Matt has been awarded an Adjunct Fellow to the School of Medicine at Western Sydney University. Matt serves as an executive Committee member (Secretary) of the Diagnostic Imaging and Monitoring Association and is a Member of the Australian Institute of Company Directors (MAICD).


Paul Flynn, CEO, The Hospital Research Foundation Group
 

Paul is an experienced, innovative, and entrepreneurial Board Director and Executive who has earned a stellar reputation for achievement during distinguished career in both the Finance and Not for Profit sector.

Paul has been acknowledged for his contribution to the Banking and Investment Industry by being awarded a Senior Fellowship of the Financial Services Institute of Australasia. Paul has also been recognised for his contribution to the not-for-profit industry by being awarded the Ernst & Young Social Entrepreneur of the Year in South Australia/Northern Territory and has also been awarded the Equity Trustees Australian Not for Profit CEO Award for Innovation. Paul has recently been awarded an Honorary Fellow of the University of South Australia. Paul is a judge of the Napier Waller National Art prize awarded by the Australian War Memorial.

Paul is a member of the Australian Institute of Company Directors and currently holds positions as a Non-Executive Director and Deputy Chair of FIA Ltd, Non-Executive Director AusHealth Pty Ltd, Non-Executive Director BiomeBank Pty Ltd, Director of Military and Emergency Services Health Australia, Governor of Pulteney Grammar School, Trustee of the Pulteney Foundation Inc. and Executive Director of Australian Prostate Cancer Research Society Ltd.

Paul is Chief Executive Officer of The Hospital Research Foundation Group and of its Australian affiliates: The Repat Foundation – The Road Home Inc; Australian Centre of Excellence for Post-traumatic Stress; Australian Breast Cancer Research; Kidney, Transplant and Diabetes Research Australia; The Centre for Creative Health; Cure for Stroke Australia; Parkinson’s SA/NT; Laurel Palliative Care Foundation, Stroke SA and Australian Heart Research.



Event Details

Feel free to forward this invitation to anyone within your organisation or networks who you think might be interested in this event.

COVID PRECAUTIONS: The safety and wellbeing of our guests and colleagues is our utmost priority. AmCham will work with the venue to ensure hygiene procedures and government guidelines are followed with social distancing measures in place, visible sanitiser stations and Covid-19 marshals. We respectfully ask you do not attend on the day if you are experiencing any flu like symptoms.

UPDATE to Terms & Conditions
If Government Health Orders change and in-person events are suspended, the AmCham program will go virtual and links will be sent to all attendees. A 50% refund will be paid to ticket holders. (Please see Terms and Conditions for specific details).
When
30/04/2021 11:45 AM - 2:00 PM
Where
Adelaide Convention Centre North Terrace ADELAIDE, SA 5000 AUSTRALIA

Program


Friday, 30 April 2021

 
Time
11:45 AM - 2:00 PM
30/04/2021 11:45 AM

Sign in to book

Register Now / Update Registration